Wealth Enhancement Advisory Services’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $77.4K | Sell |
35,520
-621
| -2% | -$1.35K | ﹤0.01% | 3151 |
|
|
2025
Q1 | $44.1K | Sell |
36,141
-15,369
| -30% | -$18.8K | ﹤0.01% | 2830 |
|
|
2024
Q4 | $66.4K | Buy |
51,510
+16,412
| +47% | +$21.2K | ﹤0.01% | 2808 |
|
|
2024
Q3 | $96.5K | Buy |
35,098
+188
| +0.5% | +$517 | ﹤0.01% | 2533 |
|
|
2024
Q2 | $78.9K | Buy |
34,910
+16,271
| +87% | +$36.8K | ﹤0.01% | 2413 |
|
|
2024
Q1 | $44.5K | Hold |
18,639
| – | – | ﹤0.01% | 2335 |
|
|
2023
Q4 | $30.9K | Hold |
18,639
| – | – | ﹤0.01% | 2220 |
|
|
2023
Q3 | $35.8K | Buy |
+18,639
| New | +$35.8K | ﹤0.01% | 2144 |
|